Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Nat Rev Microbiol. 2021 Jun;19(6):345. doi: 10.1038/s41579-021-00558-z.
This month’s Genome Watch highlights how metagenomics could link the gut microbiota and COVID-19 disease outcomes and track emerging SARS-CoV-2 variants, with the potential to inform clinical practice and public health policy.
本月的《基因组观察》重点介绍了宏基因组学如何将肠道微生物组与 COVID-19 疾病结果联系起来,并跟踪新兴的 SARS-CoV-2 变体,有可能为临床实践和公共卫生政策提供信息。